Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

NCT01004978 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

235

Enrollment

NIH

Sponsor class

Conditions

Hepatocellular Carcinoma
Unresectable Hepatocellular Carcinoma

Interventions

DRUG: Cisplatin
PROCEDURE: Computed Tomography
DRUG: Doxorubicin Hydrochloride
DRUG: Doxorubicin-Eluting Beads
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Magnetic Resonance Imaging
DRUG: Mitomycin
OTHER: Pharmacological Study
OTHER: Placebo Administration
DRUG: Sorafenib Tosylate

Sponsor

National Cancer Institute (NCI)